Industry reports
Editor highlights

Pharmaceutical Market Trends, 2010 – 2014: Key market forecasts & growth opportunities (4th Edition)

Urch Publishing
  • Publication date: October 2010
  • Report price: $ 2 336

Get this report today!

$ 2 336 - 1 User License
$ 2 422 - Hard Copy
$ 12 498 - Corporate License

Summary

Table of Contents

Data Series

Pharmaceutical Market Trends, 2010 - 2014: Key market forecasts & growth opportunities presents a detailed trend analysis of the global pharmaceutical market to the end of 2009 and forecasts until 2014. This 142 page report, from URCH Publishing, presents a series of market forecasts and growth opportunities in order to help inform pharmaceutical decision-making, particularly in the areas of corporate planning, portfolio management and market forecasting.
The report is divided into five key sections. Chapters 2-5 present historical trends for key pharmaceutical markets, key therapy areas, key products and key companies. The final report chapter outlines future pharmaceutical trends and key growth opportunities.
The data and analysis contained within the report are derived from Delphi Pharma, Company Trends Database to provide a comprehensive, consistent and up-to-date single-point reference for understanding key pharmaceutical market trends in 2010.
“The global pharmaceutical market grew to $808 billion in 2009, at a compound annual growth rate of 9.3% between 1999 and 2009. Year-on-year growth in the global pharmaceutical market decreased to 4.6% in 2009, largely as a result of cost containment in the US and major European markets and the impact of several blockbuster patent expiries in 2008 and 2009.”


Findings from the report include:


• 125 pharmaceutical drugs generated more than $1billion in global sales. The top 100 blockbuster drugs generated sales of US$285.
• The top 10 companies ranked by pharmaceutical sales generated total sales of $317 billion.
• The global pharmaceutical market is forecast to grow to $1,033 billion in 2014, an equivalent CAGR of 5.0% over the next five years.
• The leading therapy areas by global pharmaceutical sales in 2009 were CNS with a 15.8% market share and cardiovascular with 14.5%.
• The CNS pharmaceutical market will decrease from $127.8 billion in 2009 to $118.5 billion in 2014, a CAGR of -1.5%.
• In 2009 there were a total of 14 cardiovascular blockbuster products with combined sales amounting to $50.7 billion.
• The US pharmaceutical market grew by 3.0% in 2009 to $300.3 billion with highest growth in mail services and clinics.
• The major five Germany, France, Italy, Spain and the UK, together accounted for over 60% of all European pharmaceutical sales in 2009.
• Pfizer had the greatest number of blockbuster products in 2009 with 14, which includes five inherited through the acquisition of Wyeth.

READERS OF THIS REPORT WILL FIND

• Comprehensive guidance on market trends for key countries, regions, therapy areas, products and companies.
• Country profiles for leading pharma markets with market segment trends and five year forecasts.
• Therapy area profiles for leading classes, Alimentary/metabolism, Antineoplastic/immunomodulatory, Anti-infectives market, CNS, Cardiovascular and Respiratory market with key products and sales forecasts.
• Detailed profiles of 10 leading pharmaceutical and biotech products in 2009, including five year future sales forecasts.
• Detailed profiles of 10 leading pharmaceutical companies in 2009, including 2014 sales forecasts.(AstraZeneca, Bristol Myers-Squibb, Eli Lilly, GlaxoSmithKline, Johnson and Johnson, Merck & Co, Novartis, Pfizer, Roche, Sanofi-Aventis Wyeth).

USE THIS REPORT TO:

1. Rapidly gain an overview into the global and regional pharmaceutical market and the top 10 companies and products.
2. Find the new areas of pharmaceutical market growth and key opportunities for delivering successful sales growth over the next five years.
3. Support internal planning and decision-making with an external perspective founded on detailed analysis and transparent market forecasts.


REPORT COVERAGE


The report methodology provides a detailed but transparent analysis of key pharmaceutical market trends, including key markets, therapy areas, products and companies. Historical trends are formed over a three-year time horizon and future forecasts are made using a five-year future time period. Thus, the data and analysis relate to the nine-year time horizon from 2005 to 2014.

SOURCES

Two proprietary SOURCES provide the key data from which all company and product analysis has been conducted. In association with URCH Publishing, Delphi Pharma’s Product Trends Database and Company Trends Database maintain historical and forecast data for the top 125 drug brands and the leading 59 pharmaceutical companies each of which generated more than US$1 billion in global pharmaceutical sales in 2009.

Urch Publishing
  • Publication date: October 2010
  • Report price: $ 2 336

Get this report today!

$ 2 336 - 1 User License
$ 2 422 - Hard Copy
$ 12 498 - Corporate License

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Pharmaceutical Industry in Japan : Latest Reports

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • December 2013
  • by Global Data

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, ...

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked ...

Global Markets For Generic Drugs

January 2014 $ 6 650

Pharmaceutical Industry in Japan : Latest Downloads

Global Clinical Trial : Innovation and Technology Trends

  • Industry report
  • April 2014
  • 16 pages

... Complexities, and so on). Within the cro market, the largest segment was that of drug discovery. Based on various analyses, the report also anticipates that the market for clinical data management services ...

Drug and Medication Market Brief

  • Industry report
  • March 2014
  • 17 pages

... Hg introduces new recommendations designed to promote safer use of angiotensin converting enzyme inhibitors (aceis) and angiotensin receptor blockers (arbs) first-line and later-line treatment should now ...

Drug Discovery and Development Industry Brief

  • Industry report
  • March 2014
  • 47 pages
  • by Research Paper

... Learn/confirm and predict phase vi registering and labeling (maa) uncertainty confident and drug and disease paediatric strategy & investigation plan scientific advice clinical trial ...


Company Profiles

3 Companies

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.